Overview
Atelvia is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis. Atelvia is also referred to by its drug name, Risedronate, or Risendronic acid.… read more
Overview
Actonel is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent postmenopausal osteoporosis. Actonel is also indicated for men with osteoporosis and people with… read more
Overview
Calcitonin is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis in women who have been postmenopausal for at least five years. Calcitonin may be… read more
Overview
Duavee is a prescription medication approved by the Food and Drug Administration (FDA) to treat moderate to severe vasomotor symptoms of menopause, such as hot flashes and night sweats, and prevent… read more
Overview
Evista is a prescription medication approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Evista may be referred to by its drug name, Raloxifene.… read more
Overview
Miacalcin is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis in women who have been postmenopausal for at least five years. Miacalcin may be indicated… read more
Overview
Fortical is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis in women who have been postmenopausal for at least five years. Fortical may be indicated… read more
Overview
Prolia is a prescription medication approved by the Food and Drug Administration (FDA) to increase bone mass in women and men at high risk for fracture. Prolia is indicated for postmenopausal women with… read more
Overview
Raloxifene is a prescription medication approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Raloxifene is also sold under the brand name Evista.… read more
Overview
Tymlos is a prescription medication approved by the Food and Drug Administration (FDA) to treat postmenopausal women with osteoporosis who are at high risk for fracture. Tymlos may also be referred to by its… read more